Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors
- DOI
- 10.1016/j.ejim.2026.107193
- Published
- 2026-09
- Container
- European Journal of Internal Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejim.2026.107193,
title = {Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors},
author = {Kaitlin J Mayne and Matthew M Y Lee and Naveed Sattar and William G Herrington},
year = {2026},
journal = {European Journal of Internal Medicine},
doi = {10.1016/j.ejim.2026.107193},
url = {https://doi.org/10.1016/j.ejim.2026.107193}
}RIS
TY - JOUR TI - Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors AU - Kaitlin J Mayne AU - Matthew M Y Lee AU - Naveed Sattar AU - William G Herrington PY - 2026 JO - European Journal of Internal Medicine DO - 10.1016/j.ejim.2026.107193 UR - https://doi.org/10.1016/j.ejim.2026.107193 ER -
APA
Mayne, K. J., Lee, M. M. Y., Sattar, N., & Herrington, W. G. (2026). Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2026.107193
Source records
- crossref · retrieved 2026-09-26T04:57:47.346Z